Display options
Cite
Kayed R, Head E, Sarsoza F, et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener. 2007;2:18doi: 10.1186/1750-1326-2-18.
Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., Rasool, S., Gurlo, T., Butler, P., & Glabe, C. G. (2007). Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Molecular neurodegeneration, 218. https://doi.org/10.1186/1750-1326-2-18
Kayed, Rakez, et al. "Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers." Molecular neurodegeneration vol. 2 (2007): 18. doi: https://doi.org/10.1186/1750-1326-2-18
Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M, Margol L, Wu J, Breydo L, Thompson JL, Rasool S, Gurlo T, Butler P, Glabe CG. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener. 2007 Sep 26;2:18. doi: 10.1186/1750-1326-2-18. PMID: 17897471; PMCID: PMC2100048.
Copy Download .nbib Format: NLM
Share it on

Mol Neurodegener. 2007 Sep 26;2:18. doi: 10.1186/1750-1326-2-18.

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.

Molecular neurodegeneration

Rakez Kayed, Elizabeth Head, Floyd Sarsoza, Tommy Saing, Carl W Cotman, Mihaela Necula, Lawrence Margol, Jessica Wu, Leonid Breydo, Jennifer L Thompson, Suhail Rasool, Tatyana Gurlo, Peter Butler, Charles G Glabe

Affiliations

  1. Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697, USA. [email protected].

PMID: 17897471 PMCID: PMC2100048 DOI: 10.1186/1750-1326-2-18

Abstract

BACKGROUND: Amyloid-related degenerative diseases are associated with the accumulation of misfolded proteins as amyloid fibrils in tissue. In Alzheimer disease (AD), amyloid accumulates in several distinct types of insoluble plaque deposits, intracellular Abeta and as soluble oligomers and the relationships between these deposits and their pathological significance remains unclear. Conformation dependent antibodies have been reported that specifically recognize distinct assembly states of amyloids, including prefibrillar oligomers and fibrils.

RESULTS: We immunized rabbits with a morphologically homogeneous population of Abeta42 fibrils. The resulting immune serum (OC) specifically recognizes fibrils, but not random coil monomer or prefibrillar oligomers, indicating fibrils display a distinct conformation dependent epitope that is absent in prefibrillar oligomers. The fibril epitope is also displayed by fibrils of other types of amyloids, indicating that the epitope is a generic feature of the polypeptide backbone. The fibril specific antibody also recognizes 100,000 x G soluble fibrillar oligomers ranging in size from dimer to greater than 250 kDa on western blots. The fibrillar oligomers recognized by OC are immunologically distinct from prefibrillar oligomers recognized by A11, even though their sizes overlap broadly, indicating that size is not a reliable indicator of oligomer conformation. The immune response to prefibrillar oligomers and fibrils is not sequence specific and antisera of the same specificity are produced in response to immunization with islet amyloid polypeptide prefibrillar oligomer mimics and fibrils. The fibril specific antibodies stain all types of amyloid deposits in human AD brain. Diffuse amyloid deposits stain intensely with anti-fibril antibody although they are thioflavin S negative, suggesting that they are indeed fibrillar in conformation. OC also stains islet amyloid deposits in transgenic mouse models of type II diabetes, demonstrating its generic specificity for amyloid fibrils.

CONCLUSION: Since the fibril specific antibodies are conformation dependent, sequence-independent, and recognize epitopes that are distinct from those present in prefibrillar oligomers, they may have broad utility for detecting and characterizing the accumulation of amyloid fibrils and fibrillar type oligomers in degenerative diseases.

References

  1. Ann Neurol. 1999 Dec;46(6):860-6 - PubMed
  2. Proc Natl Acad Sci U S A. 2005 May 17;102(20):7115-20 - PubMed
  3. Diabetes. 2003 Sep;52(9):2304-14 - PubMed
  4. Am J Pathol. 1988 Jul;132(1):86-101 - PubMed
  5. Histopathology. 2001 Feb;38(2):120-34 - PubMed
  6. J Biol Chem. 2006 Aug 25;281(34):24414-22 - PubMed
  7. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53 - PubMed
  8. Am J Pathol. 2000 Jan;156(1):15-20 - PubMed
  9. Am J Pathol. 1999 Sep;155(3):853-62 - PubMed
  10. J Biol Chem. 1995 Nov 10;270(45):26727-30 - PubMed
  11. Science. 2003 Apr 18;300(5618):486-9 - PubMed
  12. Am J Pathol. 2000 Oct;157(4):1239-46 - PubMed
  13. J Biol Chem. 2007 Apr 6;282(14):10311-24 - PubMed
  14. Ann Neurol. 1981 Aug;10(2):184-92 - PubMed
  15. J Neurosci. 2006 Aug 2;26(31):8160-7 - PubMed
  16. Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12 - PubMed
  17. Neurodegeneration. 1996 Mar;5(1):13-7 - PubMed
  18. Histochemistry. 1985;83(1):47-56 - PubMed
  19. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5129-34 - PubMed
  20. Diabetes. 2007 May;56(5):1324-32 - PubMed
  21. Chem Biol. 1997 Feb;4(2):119-25 - PubMed
  22. J Cell Biol. 1998 May 18;141(4):1031-9 - PubMed
  23. Methods Enzymol. 2006;413:326-44 - PubMed
  24. Neurology. 2000 Mar 14;54(5):1103-9 - PubMed
  25. Neuron. 1994 Jul;13(1):45-53 - PubMed
  26. J Neuropathol Exp Neurol. 1997 Apr;56(4):321-39 - PubMed
  27. J Biol Chem. 1995 Jun 16;270(24):14786-92 - PubMed
  28. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1485-90 - PubMed

Publication Types

Grant support